[1]
S. Iannazzo, L. Pradelli, and O. Zaniolo, “Pharmacoeconomic analysis of valsartan for the treatment of chronic congestive heart failure in Italy”, FE, vol. 9, no. 3, pp. 125–135, Sep. 2008.